Eastern Bank Ionis Pharmaceuticals Inc Transaction History
Eastern Bank
- $4.96 Billion
- Q1 2025
A detailed history of Eastern Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Eastern Bank holds 300 shares of IONS stock, worth $9,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$9,897% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
399Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$534 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$408 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$278 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.68B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...